July 08, 2024
FDA approves Alzheimer’s drug donanemab
Categories: Science Updates, New FDA Drug Approvals
June 27, 2024
Alzheimer’s vision study improved with home tests
Categories: Science Updates
February 26, 2024
New Ideas in UW Alzheimer’s Research
Categories: Science Updates
December 04, 2023
UW Medicine’s Memory and Brain Wellness Center treated its first patient with the new Alzheimer’s drug, lecanemab
Categories: Science Updates, New FDA Drug Approvals
November 29, 2023
Discoveries Made Possible By You // Fall 2023
Categories: Science Updates
Highlights from the 2023 Alzheimer’s Association International Conference
Categories: Science Updates, New FDA Drug Approvals, Care & Treatment
November 21, 2023
Sleep doctor studies sleep apnea treatment for dementia prevention
Categories: Science Updates, Care & Treatment
October 04, 2023
REC Symposium Brings Together UW Alzheimer’s Research Community
Categories: Science Updates
September 25, 2023
Spotlight on Dr. Jeanne Gallée and the Role of Speech-Language Services in Dementia Care
Categories: Science Updates, Care & Treatment , Team Spotlights, Resources
September 15, 2023
Leqembi Webinar
Categories: Science Updates, New FDA Drug Approvals, Care & Treatment